Clinical Trial Update: A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1 [Phase 1]

View source ↗

Summary

This Phase 1 study assesses safety, tolerability, and pharmacokinetics of RO5303253 in healthy volunteers and patients with chronic hepatitis C genotype 1; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• RO5303253 (RO5303253)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic, Healthy Volunteer | Phase 1 | Status: COMPLETED